Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $95.4B |
| FY2017, ended Dec 31, 2017 | $96.8B |
| FY2018, ended Dec 31, 2018 | $61.5B |
| FY2019, ended Dec 31, 2019 | $79.5B |
| FY2020, ended Dec 31, 2020 | $91.2B |
| FY2021, ended Dec 31, 2021 | $129B |
| FY2022, ended Dec 31, 2022 | $115B |
| FY2023, ended Dec 31, 2023 | $126B |
| FY2024, ended Dec 31, 2024 | $179B |
| FY2025, ended Dec 31, 2025 | $261B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $294B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.8B |
| FY2017, ended Dec 31, 2017 | $32.7B |
| FY2018, ended Dec 31, 2018 | $36.6B |
| FY2019, ended Dec 31, 2019 | $36.5B |
| FY2020, ended Dec 31, 2020 | $44.6B |
| FY2021, ended Dec 31, 2021 | $59.3B |
| FY2022, ended Dec 31, 2022 | $47.4B |
| FY2023, ended Dec 31, 2023 | $46.3B |
| FY2024, ended Dec 31, 2024 | $53.5B |
| FY2025, ended Dec 31, 2025 | $58.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $66.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.40B | $3.63B |
| FY2017, ended Dec 31, 2017 | $4.29B | −$23.7B |
| FY2018, ended Dec 31, 2018 | $10.5B | $8.58B |
| FY2019, ended Dec 31, 2019 | $8.47B | $15.4B |
| FY2020, ended Dec 31, 2020 | $9.46B | −$24.8B |
| FY2021, ended Dec 31, 2021 | $21.6B | $1.63B |
| FY2022, ended Dec 31, 2022 | $11.3B | $4.96B |
| FY2023, ended Dec 31, 2023 | $8.52B | −$14.9B |
| FY2024, ended Dec 31, 2024 | $14.3B | −$15.3B |
| FY2025, ended Dec 31, 2025 | $17.2B | −$47.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.0B | −$41.5B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $122B |
| FY2017, ended Dec 31, 2017 | $110B |
| FY2018, ended Dec 31, 2018 | $131B |
| FY2019, ended Dec 31, 2019 | $134B |
| FY2020, ended Dec 31, 2020 | $156B |
| FY2021, ended Dec 31, 2021 | $261B |
| FY2022, ended Dec 31, 2022 | $242B |
| FY2023, ended Dec 31, 2023 | $242B |
| FY2024, ended Dec 31, 2024 | $182B |
| FY2025, ended Dec 31, 2025 | $164B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $187B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $202B |
| FY2017, ended Dec 31, 2017 | $231B |
| FY2018, ended Dec 31, 2018 | $238B |
| FY2019, ended Dec 31, 2019 | $255B |
| FY2020, ended Dec 31, 2020 | $266B |
| FY2021, ended Dec 31, 2021 | $301B |
| FY2022, ended Dec 31, 2022 | $308B |
| FY2023, ended Dec 31, 2023 | $318B |
| FY2024, ended Dec 31, 2024 | $312B |
| FY2025, ended Dec 31, 2025 | $356B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $438B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 26.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 398M |
| FY2017, ended Dec 31, 2017 | 380M |
| FY2018, ended Dec 31, 2018 | 368M |
| FY2019, ended Dec 31, 2019 | 346M |
| FY2020, ended Dec 31, 2020 | 346M |
| FY2021, ended Dec 31, 2021 | 338M |
| FY2022, ended Dec 31, 2022 | 335M |
| FY2023, ended Dec 31, 2023 | 326M |
| FY2024, ended Dec 31, 2024 | 312M |
| FY2025, ended Dec 31, 2025 | 297M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 291M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $6.08B | $2.11B |
| FY2017, ended Dec 31, 2017 | $6.77B | $1.77B |
| FY2018, ended Dec 31, 2018 | $3.29B | $1.83B |
| FY2019, ended Dec 31, 2019 | $5.33B | $2.02B |
| FY2020, ended Dec 31, 2020 | $1.93B | $1.92B |
| FY2021, ended Dec 31, 2021 | $5.20B | $2.35B |
| FY2022, ended Dec 31, 2022 | $3.50B | $4.08B |
| FY2023, ended Dec 31, 2023 | $5.80B | $2.08B |
| FY2024, ended Dec 31, 2024 | $8.00B | $2.66B |
| FY2025, ended Dec 31, 2025 | $12.4B | $3.44B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.0B | $3.46B |
Valuation
At current price- Market Cap
- $265B
- P/E
- 12.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.0×
- Price / Book
- 2.2×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $66.2B
- Revenue Growth YoY
- 17.8%
- Revenue CAGR 3Y
- 7.2%
- Revenue CAGR 5Y
- 5.5%
- EPS Growth YoY
- 42.6%
- Net Income Growth YoY
- 34.8%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 31.7%
- FCF Margin
- −62.7%
- Return on Equity
- 17.0%
Earnings
Trailing 12 months- Net Income
- $21.0B
- EPS (diluted)
- $64.76
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $187B
- Total Debt
- $438B
- Net Debt
- $251B
- Total Assets
- $2.13T
- Total Liabilities
- $2.00T
- Shareholders' Equity
- $123B
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$39.4B
- Capital Expenditure
- $2.16B
- Free Cash Flow
- −$41.5B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $18.00
- Beta (5Y)
- 1.29
Every ratio is calculated from the company’s reported figures.